<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-OCN-15007041</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2015-09-05</date_registration>
      <primary_sponsor>Nanjing Drum Tower Hospital affiliated to Nanjing University Medical School</primary_sponsor>
      <public_title>Collagen scaffolds loaded with human umbilical cord mesenchymal stem cells for the improvement of erectile function in men with diabets</public_title>
      <acronym />
      <scientific_title>Collagen scaffolds loaded with human umbilical cord mesenchymal stem cells for the improvement of erectile function in men with diabets</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2015-09-01</date_enrolment>
      <type_enrolment />
      <target_size>the Patients with Diabetic Erectile Dysfunction:10;the Patients with Diabetic Erectile Dysfunction:10;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=11814</url>
      <study_type>Observational study</study_type>
      <study_design>Non randomized control</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>diabetic erectile dysfunction</hc_freetext>
      <i_freetext>the Patients with Diabetic Erectile Dysfunction:hUC-MSC injection to the Corpus Cavernosum;the Patients with Diabetic Erectile Dysfunction:Collagen Scaffolds Loaded with hUC-MSC injection to the Corpus Cavernosum;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Leilei Zhu</firstname>
        <middlename />
        <lastname />
        <address>321 Zhongshan Road, Nanjing, Jiangsu, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15850725901</telephone>
        <email>zhuleilei68n@163.com</email>
        <affiliation>Nanjing Drum Tower Hospital affiliated to Nanjing University Medical School</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Yutian Dai</firstname>
        <middlename />
        <lastname />
        <address>321 Zhongshan Road, Nanjing, Jiangsu, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13913957628</telephone>
        <email>13913957628@163.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. type 1 or 2 diabetes,blood glucose controlled well, no effective with oral pde-5i;
2. have a consistent partner who is willing to engage in sexual activity more than twice per month during the study;
3. males age 20 65 years;
4. iief, ef(erectile function) domain score is under 16;
5. penile arterial insufficiency or venous leakage (doppler) at the time o inclusion: psv &lt;25 cm/sec, or psv &gt;25 cm/sec, edv&gt;5cm/sec, ri&lt;0, 75;
6. hba1c is between 6.5% 10%;
7. physical examination with no abnormalities;
8. who is willing to consent to participate in the study follow-up;
9. willing to limit alcohol intake eliminate use of recreational drugs for sexual encounters.</inclusion_criteria>
      <agemin>20</agemin>
      <agemax>65</agemax>
      <gender>Male</gender>
      <exclusion_criteria>1. severe cardiovascular disease(angina, arrhythmia, cardiac failure, stroke), kidney failure, respiratory failure; history of malignancy;
2. positive for human immunodeficiency virus (hiv), hepatitis b virus (hbv), hepatitis c virus (hcv) syphilis test;
3. testosterone level is less than 200ng/dl;
4. serum ast/alt &gt;3*upper limit of normal or creatinine &gt;1.5*upper limit of normal;
5. hba1c exhibit greater than 10%;
6. in the investigators judgment, with clinical significance of penis abnormalities, or has received penile prosthesis implantation surgery;
7. patients partner is trying to conceive during the trial period;
8. exposure to any investigational drug or procedure within 1 month prior to study entry or enrolled in a concurrent study that may confound results of this study;
9. unwilling and/or not able to give written informed consent.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>IIEF-5;SEP;GAQ;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Penile Doppler;NPT;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>National Natural Science Foundation of China (no.81170563)</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2015-08-25</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>